DCTH Delcath Systems, Inc. - Common Stock
$16,93
Preço · Ago 18, 2026
Fundamentais a partir de Ago 6, 2026
Intervalo 52 Semanas
$8–$17
95% of range
Classificação do Analista
BUY
12 analysts
Preço-Alvo
$24
+42% upside
P/E (TTM)
241.9
ROE
2.5%
Margem de Lucro Líquido
3.2%
Sobre Delcath Systems, Inc. - Common Stock Visão geral da empresa da Wikipedia
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Ler mais
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
DCTH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$16.93
Capitalização de Mercado
$587M
P/E (TTM)
241.9
EPS (TTM)
$0.07
Receita (TTM)
$85M
Rendimento div.
—
ROE
2.5%
Dívida/Capital
—
Intervalo 52 Semanas
$8 – $17
DCTH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$85M
2016-12-31
→
2025-12-31
EPS
$0.07
2017-12-31
→
2025-12-31
Fluxo de caixa livre
$21M
2018-12-31
→
2025-12-31
Margens
3.2%
2022-12-31
→
2025-12-31
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
DCTH
Mediana de Pares
P/E (TTM)
241.9
32.9
P/S (TTM)
6.9
4.6
P/B
5.3
3.5
Price / FCF (Preço / FCF)
28.0
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
DCTH
Mediana de Pares
Gross Margin (Margem Bruta)
86.2%
66.5%
Operating Margin (Margem Operacional)
0.77%
—
Net Profit Margin (Margem de Lucro Líquido)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
DCTH
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
10.9
4.8
Quick Ratio (Índice de Liquidez Seca)
5.0
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
DCTH
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
129.1%
—
Revenue CAGR 3Y (CAGR Receita 3A)
215.3%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
DCTH
Mediana de Pares
DCTH Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
12 analistas
- Compra forte 3 25,0%
- Compra 8 66,7%
- Manter 1 8,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
5 analistas · 2026-08-18
Mediana
$22.00
Média
$24.00
← Abaixo de todos os alvos
$16.93
Mín
$21.00
Máx
$32.00
Alvo mediano
$22.00
+29,9%
Alvo médio
$24.00
+41,8%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.05%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $0.07 | $-0.09 | 0.16% |
| 31 de Março de 2026 | $-0.03 | $-0.09 | 0.06% |
| 31 de Dezembro de 2025 | $-0.05 | $-0.06 | 0.01% |
| 30 de Setembro de 2025 | $0.02 | $0.02 | -0.00% |
| 30 de Junho de 2025 | $0.07 | $0.03 | 0.04% |
| 31 de Março de 2025 | $0.03 | $0.02 | 0.01% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
Balanço Patrimonial 25
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
Taxas de Crescimento 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
Demonstração de Resultados 16
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
Balanço Patrimonial 23
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
Lucratividade 8
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $85M | $37M | $2M | $3M | $4M |
| Margem Bruta % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| Margem Operacional % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| Lucro líquido | $3M | $-26M | $-48M | $-37M | $-26M |
| EPS Diluído | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| Índice de Liquidez Seca | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $21M | $-19M | $-31M | $-25M | $-23M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 140 declarantes · $188.2M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 27 (0 vs trimestre anterior) | 17 (-3 vs trimestre anterior) | 40 (+6 vs trimestre anterior) | 30 (-7 vs trimestre anterior) | +1.7M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41.551.898 | 3.300.389 | 22,08% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.375.500 | 1.221.247 | 8,17% | Ações |
| VANGUARD GROUP INC | $14.879.573 | 1.473.225 | 7,91% | Ações |
| Propel Bio Management, LLC | $10.971.681 | 871.460 | 5,83% | Ações |
| STATE STREET CORP | $8.552.135 | 679.280 | 4,55% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $7.923.535 | 629.139 | 4,21% | Ações |
| ALGERT GLOBAL LLC | $7.311.114 | 580.708 | 3,89% | Ações |
| MILLENNIUM MANAGEMENT LLC | $7.130.611 | 566.371 | 3,79% | Ações |
| Divisadero Street Capital Management, LP | $6.292.432 | 499.796 | 3,34% | Ações |
| ExodusPoint Capital Management, LP | $4.530.940 | 359.884 | 2,41% | Ações |
| Private Wealth Advisors, LLC | $3.913.765 | 310.863 | 2,08% | Ações |
| Simplify Asset Management Inc. | $3.333.454 | 264.770 | 1,77% | Ações |
| BlackRock, Inc. | $3.180.738 | 252.640 | 1,69% | Ações |
| ADAR1 Capital Management, LLC | $2.825.007 | 224.385 | 1,50% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $2.570.450 | 204.166 | 1,37% | Ações |
| KENNEDY CAPITAL MANAGEMENT LLC | $2.570.160 | 204.143 | 1,37% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.435.510 | 193.448 | 1,29% | Ações |
| Ikarian Capital, LLC | $2.337.548 | 185.667 | 1,24% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $2.290.159 | 181.903 | 1,22% | Ações |
| CIBC WORLD MARKET INC. | $2.054.789 | 163.208 | 1,09% | Ações |
| Caption Management, LLC | $1.894.795 | 150.500 | 1,01% | Opção de venda |
| GOLDMAN SACHS GROUP INC | $1.885.353 | 149.750 | 1,00% | Ações |
| Lane Generational LLC | $1.884.257 | 149.663 | 1,00% | Ações |
| HSBC HOLDINGS PLC | $1.705.848 | 135.600 | 0,91% | Ações |
| Man Group plc | $1.617.752 | 128.495 | 0,86% | Ações |
| Cubist Systematic Strategies, LLC | $1.562.514 | 145.350 | 0,83% | Ações |
| Diametric Capital, LP | $1.546.568 | 122.841 | 0,82% | Ações |
| MORGAN STANLEY | $1.366.506 | 108.539 | 0,73% | Ações |
| BARCLAYS PLC | $1.354.243 | 107.565 | 0,72% | Ações |
| Caption Management, LLC | $1.259.000 | 100.000 | 0,67% | Opção de compra |
| Capital Advisors Wealth Management, LLC | $1.170.870 | 93.000 | 0,62% | Ações |
| Jefferies Financial Group Inc. | $1.057.308 | 83.980 | 0,56% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.050.824 | 83.465 | 0,56% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.022.308 | 81.200 | 0,54% | Opção de compra |
| Stonepine Capital Management, LLC | $1.000.000 | 100.000 | 0,53% | Opção de compra |
| Caption Management, LLC | $978.243 | 77.700 | 0,52% | Ações |
| FOX RUN MANAGEMENT, L.L.C. | $776.526 | 61.678 | 0,41% | Ações |
| Quantbot Technologies LP | $749.860 | 59.560 | 0,40% | Ações |
| D. E. Shaw & Co., Inc. | $728.885 | 57.894 | 0,39% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $725.864 | 57.654 | 0,39% | Ações |
| Pale Fire Capital SE | $504.670 | 40.085 | 0,27% | Ações |
| BANK OF AMERICA CORP /DE/ | $493.931 | 39.232 | 0,26% | Ações |
| WOLVERINE TRADING, LLC | $479.600 | 44.000 | 0,25% | Opção de compra |
| RHUMBLINE ADVISERS | $458.822 | 36.444 | 0,24% | Ações |
| ALPS ADVISORS INC | $441.154 | 35.040 | 0,23% | Ações |
| EntryPoint Capital, LLC | $437.641 | 34.761 | 0,23% | Ações |
| SEI INVESTMENTS CO | $394.936 | 31.369 | 0,21% | Ações |
| AMERICAN CENTURY COMPANIES INC | $378.380 | 30.054 | 0,20% | Ações |
| Balyasny Asset Management L.P. | $358.412 | 28.468 | 0,19% | Ações |
| Leonteq Securities AG | $348.730 | 27.699 | 0,19% | Ações |
| CITADEL ADVISORS LLC | $334.894 | 26.600 | 0,18% | Opção de compra |
| BOOTHBAY FUND MANAGEMENT, LLC | $319.484 | 25.376 | 0,17% | Ações |
| Xcelsior Advisor Partners LLC | $318.527 | 25.300 | 0,17% | Ações |
| Palisades Investment Partners, LLC | $293.007 | 23.273 | 0,16% | Ações |
| WOLVERINE TRADING, LLC | $269.666 | 24.740 | 0,14% | Ações |
| ALLIANCEBERNSTEIN L.P. | $239.424 | 25.800 | 0,13% | Ações |
| MetLife Investment Management, LLC | $235.043 | 18.669 | 0,12% | Ações |
| Bank of New York Mellon Corp | $234.942 | 18.661 | 0,12% | Ações |
| WealthPlan Investment Management, LLC | $219.607 | 17.443 | 0,12% | Ações |
| NOMURA HOLDINGS INC | $210.530 | 16.722 | 0,11% | Ações |
| WOLVERINE TRADING, LLC | $209.280 | 19.200 | 0,11% | Opção de venda |
| CITADEL ADVISORS LLC | $202.699 | 16.100 | 0,11% | Opção de venda |
| CITADEL ADVISORS LLC | $189.391 | 15.043 | 0,10% | Ações |
| SkyOak Wealth, LLC | $188.850 | 15.000 | 0,10% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188.850 | 15.000 | 0,10% | Opção de venda |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166.729 | 13.243 | 0,09% | Ações |
| TUDOR INVESTMENT CORP ET AL | $151.609 | 12.042 | 0,08% | Ações |
| LANARK FINANCIAL, INC. | $150.500 | 11.954 | 0,08% | Ações |
| CITIGROUP INC | $146.485 | 11.635 | 0,08% | Ações |
| Invesco Ltd. | $143.790 | 11.421 | 0,08% | Ações |
| MERCER GLOBAL ADVISORS INC /ADV | $140.744 | 11.179 | 0,07% | Ações |
| Nuveen, LLC | $138.754 | 11.021 | 0,07% | Ações |
| Vanguard Global Advisers, LLC | $133.869 | 10.633 | 0,07% | Ações |
| Schonfeld Strategic Advisors LLC | $131.136 | 10.416 | 0,07% | Ações |
| LPL Financial LLC | $128.859 | 10.235 | 0,07% | Ações |
| TWO SIGMA INVESTMENTS, LP | $126.580 | 10.054 | 0,07% | Ações |
| Police & Firemen's Retirement System of New Jersey | $110.729 | 8.795 | 0,06% | Ações |
| SHERBROOKE PARK ADVISERS LLC | $109.918 | 10.883 | 0,06% | Ações |
| Hunting Hill Global Capital, LLC | $104.716 | 11.284 | 0,06% | Ações |
| MARSHALL WACE, LLP | $84.177 | 6.686 | 0,04% | Ações |
| FMR LLC | $69.144 | 5.492 | 0,04% | Ações |
| Private Wealth Advisors, LLC | $62.950 | 5.000 | 0,03% | Opção de compra |
| NEW YORK STATE COMMON RETIREMENT FUND | $60.432 | 4.800 | 0,03% | Ações |
| OSAIC HOLDINGS, INC. | $60.254 | 4.786 | 0,03% | Ações |
| Point72 (DIFC) Ltd | $53.931 | 5.017 | 0,03% | Ações |
| NORTHERN TRUST CORP | $53.797 | 4.273 | 0,03% | Ações |
| Persistent Asset Partners Ltd | $52.954 | 4.206 | 0,03% | Ações |
| Arax Advisory Partners | $51.884 | 4.121 | 0,03% | Ações |
| IFP Advisors, Inc | $51.657 | 4.103 | 0,03% | Ações |
| Integrated Wealth Concepts LLC | $48.145 | 3.824 | 0,03% | Ações |
| Ameritas Investment Partners, Inc. | $38.714 | 3.075 | 0,02% | Ações |
| Legal & General Group Plc | $34.534 | 2.743 | 0,02% | Ações |
| CWM, LLC | $29.343 | 3.162 | 0,02% | Ações |
| Creative Planning | $17.777 | 1.412 | 0,01% | Ações |
| Tripletail Wealth Management, LLC | $16.632 | 1.260 | 0,01% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14.950 | 1.611 | 0,01% | Ações |
| AlphaQuest LLC | $14.473 | 1.433 | 0,01% | Ações |
| Tower Research Capital LLC (TRC) | $13.711 | 1.089 | 0,01% | Ações |
| Activest Wealth Management | $12.590 | 1.000 | 0,01% | Ações |
| Geneos Wealth Management Inc. | $11.621 | 923 | 0,01% | Ações |
Executivos da empresa 46 insiders · 11 diretores · 16 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 8 de Maio de 2020 C | 25.021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 8 de Maio de 2020 C | 12.851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 30 de Novembro de 2007 A | 3.375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 13 de Outubro de 2023 P | 41.526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 29 de Maio de 2007 P | 160.375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 12 de Dezembro de 2023 P | 100.000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 17 de Novembro de 2023 P | 30.000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 16 de Novembro de 2023 P | 40.000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 12 de Junho de 2023 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 12 de Junho de 2023 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 1 de Setembro de 2021 A | — | 0 | 0 | $0 |
| John Richard Sylvester | Conselheiro | 21 de Agosto de 2023 P | 10.550 | 0 | 0 | $0 |
| Aharon Gil | Conselheiro | 12 de Junho de 2023 A | 404.000 | 0 | 0 | $0 |
| Steven A J Salamon | Conselheiro | 12 de Junho de 2023 A | 440.100 | 0 | 0 | $0 |
| Roger G Stoll PHD | Conselheiro | 12 de Junho de 2023 A | 9.309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | Conselheiro | 19 de Abril de 2022 P | 433.100 | 0 | 0 | $0 |
| Marco Taglietti | Conselheiro | 8 de Maio de 2020 C | 6.000 | 0 | 0 | $0 |
| William Dodge Rueckert | Conselheiro | 8 de Maio de 2020 C | 6.014 | 0 | 0 | $0 |
| Simon Pedder | Conselheiro | 1 de Fevereiro de 2019 A | — | 0 | 0 | $0 |
| Laura A Philips | Conselheiro | 23 de Julho de 2015 P | 205.299 | 0 | 0 | $0 |
| Harold S Koplewicz | Conselheiro | 10 de Junho de 2015 A | 45.052 | 0 | 0 | $0 |
| Dennis Langer | Conselheiro | 10 de Junho de 2015 A | 20.000 | 0 | 0 | $0 |
| Jonathan Lewis | Conselheiro | 30 de Junho de 2008 A | 10.000 | 0 | 0 | $0 |
| Mark Corigliano | Conselheiro | 16 de Abril de 2007 M | 198.176 | 0 | 0 | $0 |
| Daniel Isdaner | Conselheiro | 16 de Abril de 2007 M | 253.668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 13 de Maio de 2026 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 2 de Março de 2026 P | 342.034 | 2 | 0 | $198.447 |
| Laura Brege | — | 7 de Julho de 2014 A | 11.678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 7 de Julho de 2014 A | 11.678 | 0 | 0 | $0 |
| Gabriel Leung | — | 7 de Julho de 2014 A | 21.485 | 0 | 0 | $0 |
| Douglas G Watson | — | 7 de Julho de 2014 A | 136.664 | 0 | 0 | $0 |
| Graham G Miao | — | 14 de Novembro de 2013 A | 54.000 | 0 | 0 | $0 |
| Peter J Graham | — | 14 de Novembro de 2013 A | 15.000 | 0 | 0 | $0 |
| William M Appling | — | 15 de Julho de 2013 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 11 de Março de 2013 A | 159.000 | 0 | 0 | $0 |
| Harold Mapes | — | 11 de Março de 2013 A | 17.000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 11 de Março de 2013 A | 162.000 | 0 | 0 | $0 |
| Agustin V Gago | — | 11 de Março de 2013 A | 80.944 | 0 | 0 | $0 |
| Robert Ladd | — | 15 de Junho de 2012 A | 69.534 | 0 | 0 | $0 |
| David Mcdonald | — | 10 de Março de 2011 A | 47.706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 1 de Dezembro de 2010 A | 8.507 | 0 | 0 | $0 |
| Richard Taney | — | 10 de Dezembro de 2009 A | 211.485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 12 de Outubro de 2009 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 26 de Janeiro de 2007 X | 775.360 | 0 | 0 | $0 |
| Victor Nevins | — | 12 de Outubro de 2006 M | 180.007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 10 de Novembro de 2004 J | 892.649 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 17 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 declarações | 10 de Fevereiro de 2026 | 9,90% | Emenda | — | SEC |
| Pessoa de relato não divulgada | 16 de Dezembro de 2022 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 27 de Julho de 2022 | — | Declaração inicial | — | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 declarações | 2 de Agosto de 2010 | — | Declaração inicial | — | SEC |
| Robert Ladd | 18 de Outubro de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 28 de Julho de 2006 | — | Declaração inicial | Campanha no conselho | SEC |
| Pessoa de relato não divulgada | 11 de Julho de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 14 de Junho de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 8 de Junho de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 24 de Maio de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 28 de Abril de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 10 de Janeiro de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 6 de Janeiro de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 14 de Dezembro de 2005 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 10 de Novembro de 2005 | — | Declaração inicial | Campanha no conselho | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 22 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,24% | 35.814 NS | 31 de Maio de 2026 | N-PORT |
| IWC · iShares Trust | 0,10% | 97.850 SH | 8 de Agosto de 2026 | Diário |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 35.321 NS | 31 de Maio de 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 227.534 SH | 8 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 21.358 SH | 8 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,01% | 741.852 SH | 8 de Agosto de 2026 | Diário |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.388 SH | 8 de Agosto de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 165.177 SH | 8 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,01% | 13.080 NS | 30 de Abril de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 22.609 NS | 31 de Maio de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1.420 NS | 31 de Maio de 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.111 NS | 31 de Maio de 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 38.572 SH | 8 de Agosto de 2026 | Diário |
| URTY · ProShares Trust | 0,00% | 1.122 NS | 31 de Maio de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.638 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 28 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19.222 NS | 30 de Abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43.750 SH | 8 de Agosto de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 304.809 SH | 8 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 889.410 SH | 8 de Agosto de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.438 SH | 8 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.475 SH | 8 de Agosto de 2026 | Diário |